Home Health Care Zaltrap granted priority review by FDA

Zaltrap granted priority review by FDA

SHARE

Zaltrap, currently in clinical trials after being developed by Regeneron Pharmaceuticals Inc. and Sanofi, has been granted priority review by the FDA.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email